Alkermes Announces FDA Orphan Drug Designation for Nemvaleukin Alfa for Treatment of Mucosal Melanoma
March 11, 2021| Source: PRNewswire Alkermes plc (Nasdaq: ALKS) today announced that nemvaleukin alfa (“nemvaleukin”, formerly referred to as…
02/05/2021
Alkermes Announces FDA Orphan Drug Designation for Nemvaleukin Alfa for Treatment of Mucosal Melanoma
March 11, 2021| Source: PRNewswire Alkermes plc (Nasdaq: ALKS) today announced that nemvaleukin alfa (“nemvaleukin”, formerly referred to as…
|
|
02/05/2021
“A Celebration of Friendship” Solo Exhibit Shares Heartfelt Story While Raising Funds for AIM at Melanoma Foundation
Contact: Chris Miller (972) 788-2599 Publicity cjmiller@rainmakeradv.com (RICHARDSON, TEXAS) How do we honor the meaning of friendship and the potential…
|
|
02/05/2021
Survivor Spotlight: Mark Lewis, Stage III Melanoma Survivor
A Partner Through It All By Mara Klecker Mark Lewis was less than a year into his relationship when he…
|
02/05/2021
Art Exhibit to Honor a Friendship and Raise Funds for AIM
By Mara Klecker Melanie Brannan has had difficulty falling asleep in recent weeks. Throughout the day and into the night,…
|
|
01/26/2021
FDA Grants Toripalimab Fast Track Designation for Mucosal Melanoma
January 24, 2021 19:07 ET | Source: Junshi Biosciences Junshi Biosciences (HKEX: 1877; SSE: 688180), an innovation-driven biopharmaceutical…
|
|
01/10/2021
In Plain English—Intratumoral Injection: Boosting the immune response against metastatic melanoma by the direct injection of immunotherapy into tumor masses
By Kim Margolin, M.D. Using the patient’s own immune system to combat melanoma is a powerful tool for patients…
|
01/08/2021
President’s Letter | January 2021
From the Desk of Samantha Guild In a January newsletter it is traditional to wish you a happy new year…
|
01/08/2021
Why Is the Tissue Bank So Important For Melanoma Research?
We answer this question with the help of Mohammed Kashani-Sabet, M.D., the Director, Center for Melanoma Research and Treatment;…
|
01/08/2021
What is Oral Parity, and Why Does it Matter?
We answer this question with the help of a pharmacist at a large oncology practice who wishes to remain…
|
01/08/2021
AIM Launches a New Program That Addresses the Emotional Needs of Melanoma Patients
by Mara Klecker Amid the COVID-19 pandemic, AIM at Melanoma has redoubled its efforts to meet the needs of melanoma…
Recent Posts
Apr. 16, 2024
Navigating the Journey Together – Conversations with Melanoma Caregivers
Apr. 12, 2024
May is Brain Tumor Awareness Month
Apr. 11, 2024
President’s Letter | April 2024
Apr. 11, 2024
Celebrating a Milestone: 20 Years of the Dallas Steps Against Melanoma Walk
Apr. 11, 2024